Determination of related substances of levodopa including the R-enantiomer by CE
✍ Scribed by Sudaporn Wongwan; Manuela Hammitzsch-Wiedemann; Gerhard K. E. Scriba
- Book ID
- 102184870
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 205 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0173-0835
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A CE assay for the simultaneous determination of the impurities of levodopa listed in the European Pharmacopoeia including the (R)‐enantiomer was developed and validated. The analysis was performed in a fused‐silica capillary employing sulfated β‐cyclodextrin as chiral selector at an applied voltage of 20 kV and a temperature of 18°C. The optimized background electrolyte consisted of 0.1 M sodium phosphate buffer, pH 2.0, containing 6 mg/mL sulfated β‐cyclodextrin. L‐phenylalanine was used as the internal standard. The assay was validated in the range of 0.1–1.0% for the impurities at a concentration of levodopa of 2 mg/mL. The effect of different batches of sulfated β‐cyclodextrin was investigated using levodopa and L‐tyrosine as critical pair. The method was applied to determine the purity of several samples of levodopa including the chemical reference substance of the European Pharmacopoeia.
📜 SIMILAR VOLUMES
## Abstract A cyclodextrin‐modified micellar electrokinetic chromatographic (CD‐MEKC) method for the determination of the most important potential impurities of methotrexate (MTX): 2,4‐diamino‐6‐(hydroxymethyl)pteridine, aminopterine hydrate, 4‐[__N__‐(2‐amino‐4‐hydroxy‐6‐pteridinylmethyl)‐__N__‐me
The validation of the HPLC method used for the determination of cefdinir and its related substances is described. The developed method was specific and stability-indicating and provided a linear response with concentration. The system and method precision, expressed as relative standard deviations,